| Protocol No. | Title | Status |
| 02-0495-01 | Evaluation of the Ovary: An IN VIVO Pilot Study (Sub-Study: Optical Spectroscopy of Ovarian Cancer) | Open |
| 06-0477-04 | DATABASE FOR INDIVIDUALS AT HIGH RISK FOR BREAST, OVARIAN AND OTHER HEREDITARY CANCERS | Open |
| 10-0857-10 | GOG0262_ A RANDOMIZED PHASE III TRIAL OF EVERY-3-WEEKS PACLITAXEL VERSUS DOSE
DENSE WEEKLY PACLITAXEL IN COMBINATION WITH CARBOPLATIN WITH OR
WITHOUT CONCURRENT AND CONSOLIDATION BEVACIZUMAB (NSC #704865, IND
#7921) IN THE TREATMENT OF PRIMARY STAGE III OR IV EPITHELIAL OVARIAN,
PERITONEAL OR FALLOPIAN TUBE CANCER | Open |
| 12-0138-04 | Biospecimen Repository for Individuals at High Risk for Breast, Ovarian, or Other Hereditary Cancers | Open |
| 12-0320-04 | Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube Cancer (GOG 273) | Open |
| 12-0698-04 | THE LYMPHEDEMA AND GYNECOLOGIC CANCER (LEG) STUDY: INCIDENCE, RISK FACTORS, AND IMPACT IN NEWLY DIAGNOSED PATIENTS (GOG 244) | Open |
| 20101591 | A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/DOXIL®/CAELYX®) in Combination Versus PLD in Participants with Platinum-Resistant Ovarian Cancer
| Open |
| COGAGCT0521 | Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors with Paclitaxel, Ifosfamide and Carboplatin (COG AGCT0521) | Open |